COQ8A-Ataxia as a Manifestation of Primary Coenzyme Q Deficiency

9Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

COQ8A-ataxia is a mitochondrial disease in which a defect in coenzyme Q10 synthesis leads to dysfunction of the respiratory chain. The disease is usually present as childhood-onset progressive ataxia with developmental regression and cerebellar atrophy. However, due to variable phenotype, it may be hard to distinguish from other mitochondrial diseases and a wide spectrum of childhood-onset cerebellar ataxia. COQ8A-ataxia is a potentially treatable condition with the supplementation of coenzyme Q10 as a main therapy; however, even 50% may not respond to the treatment. In this study we review the clinical manifestation and management of COQ8A-ataxia, focusing on current knowledge of coenzyme Q10 supplementation and approach to further therapies. Moreover, the case of a 22-month-old girl with cerebellar ataxia and developmental regression will be presented.

Cite

CITATION STYLE

APA

Paprocka, J., Nowak, M., Chuchra, P., & Śmigiel, R. (2022, October 1). COQ8A-Ataxia as a Manifestation of Primary Coenzyme Q Deficiency. Metabolites. MDPI. https://doi.org/10.3390/metabo12100955

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free